Pharma
Challenges plaguing primary care
An In-depth Conversation with Dr. David Buckley, Trinity Court Surgery In an exclusive interview with Dr. David Buckley, a seasoned General Practitioner, we delve into the pressing issues confronting primary care in the UK. The escalating wait times to see a GP, now extending to a mont...
Drug Discovery 2024
Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, ...
ELRIG UK announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024
Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October ...
Molecular Dynamics in Flare™: a User-Friendly and Effective Solution to Enhance Drug Discovery
Date Date: Wednesday 15th May 2024 Time: 3pm BST / 4pm CEST / 10am ET / 7am PST Duration: 45 minutes Format: Webinar ...
Guardtech Group off to a stormer in 2024 as action-packed quarter one flies by
Haverhill-based cleanroom design & build experts are working on more than 20 significant projects concurrently – an all-time high ...
Registration open for our Scientific Conference in June
We are excited to announce that you can now secure your spot for the 2nd NIHR BioResource Scientific Conference, taking place online on Wednesday 19 June 2024 from 9.30am to 12.30pm. ...
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth. ...
Navigating payer challenges in rare disease
Clinical and economic evidence generation across rare diseases is challenging due to intrinsic disease characteristics, misalignment on treatment costs, and inadequate traditional evaluation frameworks. Therefore, rare disease products face unique payer challenges, which need to be comp...
Improving adherence in Asthma treatment
Asthma, a common respiratory disorder affects more than 8 million people in the UK alone [1]. Despite the availability of effective treatments, inhaled corticosteroids (ICS) which are the mainstay of asthma treatment, often show limited efficacy because of suboptimal patient adherence. ...
AI at the Frontier: Empowering Early Career Professionals in Drug Discovery
ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Join us for an insightful webinar where industry experts will delve into the transformative role of AI in revolutionising drug discovery and how it will impact your career in drug discove...